Patient Guide: A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 30 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05537740
Status: 🟢 Enrolling Now
Condition: Advanced Solid Tumors
Phase: PHASE1

Where You Can Participate

This study is available at 30 locations across the country.

Top locations include:
  • • Chicago, Illinois
  • • Chapel Hill, North Carolina
  • • Columbus, Ohio
  • • And 27 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors - Join Clinical Trial NCTNCT05537740

How to Join This Clinical Trial - NCTNCT05537740

Learn how to participate in this PHASE1 trial studying an investigational therapy for Advanced Solid Tumors. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced Solid Tumors. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced Solid Tumors
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05537740 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 30 locations. Find a study site near you:

Clinical Research Site

Chicago, Illinois 60637 - United States

Status: RECRUITING

Clinical Research Site

Chapel Hill, North Carolina 27514 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Columbus, Ohio 43210 - United States

Status: WITHDRAWN

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: RECRUITING

Clinical Research Site

West Valley City, Utah 84119 - United States

Status: RECRUITING

Clinical Research Site

Antwerpen, 2650 - Belgium

Status: RECRUITING

Clinical Research Site

Gent, 9000 - Belgium

Status: RECRUITING

Clinical Research Site

Leuven, 3000 - Belgium

Status: RECRUITING

Clinical Research Site

Liege, 4000 - Belgium

Status: NOT_YET_RECRUITING

Clinical Research Site

Edmonton, Alberta T6G 1Z2 - Canada

Status: NOT_YET_RECRUITING

And 20 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Advanced Solid Tumors:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships